S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Merrimack Pharmaceuticals Reports Third Quarter 2014 Financial Results|
|FDA Grants Orphan Drug Designation to Merrimack Pharmaceuticals' MM-141 for the Treatment of Pancreatic Cancer|
|Mack-Cali Realty Corporation Announces Third Quarter Results|
|Merrimack Pharmaceuticals Presents on Multiple Programs at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics|
|Merrimack Pharmaceuticals Presents Research on Innovative Pipeline for Patients With Breast Cancer at the 2014 San Antonio Breast Cancer Symposium|
|Photo Release -- Merrimack Pharmaceuticals Announces the Addition of Vivian S. Lee, Dean of University of Utah School of Medicine, to Its Board of Directors|
|Merrimack Pharmaceuticals Announces the Addition of Russell T. Ray to Its Board of Directors|
|Merrimack Pharmaceuticals to Present at Oppenheimer 25th Annual Healthcare Conference, Hold Analyst Day and Present Research on Multiple Molecules in December 2014|
|Merrimack Pharmaceuticals Announces Timing of Third Quarter 2014 Investor Conference Call|
|Merrimack Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference|
Click above to view more mutual fund data and stats for mack - Merrimack Pharmaceuticals Inc.